| Recruiting | 3 | 1700 | Europe, Canada, Japan, US, RoW | GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS) | GlaxoSmithKline, Iqvia Pty Ltd | Asthma | 09/25 | 09/25 | | |
NCT05592769: A Pilot Study to Assess the Suitability of the HealthBeacon Injection Care Management System (ICMS) as a Remote Therapeutic Monitoring (RTM) Device |
|
|
| Enrolling by invitation | N/A | 10 | US | HealthBeacon Injection Care Management System (ICMS) | HealthBeacon Plc, Modena Allergy & Asthma | Respiratory Disease | 11/23 | 11/23 | | |